KCPG
GWPH

Kavar Capital Partners Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Kavar Capital Partners Group’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-150
Closed -$26K – 493
2019
Q2 		$26K Buy
+150
New +$25.9K 0.01% 290
2018
Q3 		– Sell
-150
Closed -$21K – 426
2018
Q2 		$21K Buy
+150
New +$21.3K 0.01% 263

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kavar Capital Partners Group's GWPH Position: Q3 2019 in Review

Kavar Capital Partners Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 150 shares — an estimated $26K sold.

Kavar Capital Partners Group first reported a position in GWPH in Q2 2018 and held it in 2 quarters. The position peaked at $26K in Q2 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

  • Kavar Capital Partners Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
  • Kavar Capital Partners Group sold 150 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $26K.
  • Kavar Capital Partners Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 2 quarters.
  • Kavar Capital Partners Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $26K in Q2 2019.
  • 316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Kavar Capital Partners Group's 13F filing for Q3 2019, filed 12 Nov 2019.